A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Cynthia A ThomsonH H Sherry ChowBetsy C WertheimDenise J RoeAlison StopeckGertraud MaskarinecMaria AltbachPavani ChalasaniChuan HuangMeghan B StromJean-Philippe GalonsPatricia A Thompson

Published in: Breast cancer research and treatment (2017)

ClinicalTrials.gov NCT01391689.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
positive breast cancer
patient reported